Related Experiment Video

Updated: Jun 15, 2026

Bronchial Thermoplasty: A Novel Therapeutic Approach to Severe Asthma
14:39

Bronchial Thermoplasty: A Novel Therapeutic Approach to Severe Asthma

Published on: November 4, 2010

Long-term maintenance of pediatric asthma: focus on budesonide/formoterol inhalation aerosol

Peter N Huynh1, Lyne G Scott, Kenny Yc Kwong

  • 1Division of Allergy-Immunology, Department of Pediatrics, Los Angeles County, University of Southern California Medical Center, Los Angeles, CA, USA;

Therapeutics and Clinical Risk Management
|March 18, 2010
PubMed

Insights

Current asthma guidelines emphasize achieving control in children. This review focuses on budesonide and formoterol, a safe and effective combination therapy for pediatric asthma management.

Area of Science:

  • Pediatric Pulmonology
  • Asthma Management
  • Pharmacotherapy

Background:

  • Asthma guidelines recommend treatment to achieve and maintain asthma control in children.
  • Stricter recommendations exist for uncontrolled asthma to reduce morbidity and mortality.
  • Newer combination agents offer improved safety and efficacy.

Purpose of the Study:

  • To review the control of pediatric asthma.
  • To focus on the use of budesonide in combination with formoterol.
  • To highlight effective asthma management strategies for children.

Main Methods:

  • Literature review of current asthma guidelines.
  • Analysis of studies on combination inhaler therapies for pediatric asthma.
  • Discussion of treatment adherence and co-morbidities.

Main Results:

  • Budesonide and formoterol combination is safe and effective for pediatric asthma.
  • Combination therapy, improved compliance, and co-morbidity management aid asthma control.
  • Current guidelines support intensified therapy for uncontrolled pediatric asthma.

Conclusions:

  • Budesonide and formoterol represent a valuable option for pediatric asthma control.
  • Comprehensive management including controller agents and adherence is key.
  • Adherence to guidelines can significantly improve outcomes in childhood asthma.

Keywords:
asthmabudesonidechildrencontrolformoterollong-term

Related Concept Videos

Inhaled Medications01:23

Inhaled Medications

Inhaled medications are crucial for managing chronic obstructive pulmonary disease (COPD) and asthma. They are essential for effective treatment and control, ensuring optimal respiratory health and well-being. Inhaled medication delivers drugs directly to the lungs, providing a rapid onset of action and reducing systemic side effects compared to oral or injectable medications. Three primary types of inhalation devices are used to administer these medications: nebulizers, metered-dose inhalers...
COPD: Management Using Bronchodilators and Corticosteroids01:26

COPD: Management Using Bronchodilators and Corticosteroids

Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids01:25

Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids

Inhaled corticosteroids (ICS) are anti-inflammatory drugs used primarily in treating persistent asthma and providing long-term maintenance. They target the bronchial mucosa, the lining of the airways, to control inflammation, a critical factor in asthma progression and exacerbation.
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
Antiasthma Drugs: β2-Adrenoceptor Agonists01:25

Antiasthma Drugs: β2-Adrenoceptor Agonists

Bronchodilators are critical in managing asthma, a chronic respiratory condition characterized by airway constriction due to inflammation and hyper-reactivity. Specifically, bronchodilators ease this constriction by relaxing the bronchial muscles, facilitating easier breathing.
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce relaxation in these...
Asthma-IV: Diagnostic and Management01:30

Asthma-IV: Diagnostic and Management

The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Drugs Used in Lower Respiratory Disorders: Overview01:17

Drugs Used in Lower Respiratory Disorders: Overview

Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...